Condition
Gastrointestinal Lesions
Total Trials
6
Recruiting
3
Active
3
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 4 (1)
Trial Status
Completed3
Recruiting3
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07748923CompletedPrimary
Photon-Counting CT for Detection of Small Gastrointestinal Lesions
NCT07625189Recruiting
EUS-Guided Ablation (RFA and MWA) for Pancreatic and Other Gastrointestinal Lesions Registry
NCT05468008Recruiting
Endoscopic Submucosal Dissection (ESD)
NCT05226221Recruiting
Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality
NCT02632812Phase 1CompletedPrimary
Gastrointestinal Integrity After Naproxen + Rebamipide Versus Naproxen + Placebo
NCT00652834Phase 4CompletedPrimary
Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®
Showing all 6 trials